Focus Partners Advisor Solutions’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$275K Buy
+1,243
New +$271K ﹤0.01% 1141
2025
Q3
– Sell
-1,154
Closed -$297K – 1262
2025
Q2
$297K Sell
1,154
-688
-37% -$164K ﹤0.01% 866
2025
Q1
$412K Sell
1,842
-136
-7% -$31.8K 0.01% 646
2024
Q4
$452K Buy
1,978
+352
+22% +$84.8K 0.01% 497
2024
Q3
$397K Buy
+1,626
New +$363K 0.01% 497

Other funds holding RMD

Focus Partners Advisor Solutions's RMD Position: Q3 2026 in Review

Focus Partners Advisor Solutions opened a new position in ResMed (RMD) in Q3 2026: 1,243 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #1141 among its holdings. This is a return to the name: Focus Partners Advisor Solutions previously reported a position in RMD as recently as Q2 2025.

Focus Partners Advisor Solutions first reported a position in RMD in Q3 2024 and has held it in 5 quarters since. The position peaked at $452K in Q4 2024. 535 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Focus Partners Advisor Solutions held 1,243 shares of ResMed worth $275K as of Q3 2026.
  • ResMed was a new Focus Partners Advisor Solutions position in Q3 2026.
  • ResMed made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q3 2026, its #1141 holding.
  • Focus Partners Advisor Solutions first reported a position in ResMed in Q3 2024 and has held it in 5 quarters since.
  • Focus Partners Advisor Solutions's ResMed position peaked at $452K in Q4 2024.
  • 535 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.